NCT00193323View on ClinicalTrials.gov

Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

346

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

May 31, 2006

Study Completion Date

January 31, 2009

Conditions

Lung Cancer

Interventions

DRUG

Docetaxel

DRUG

Gemcitabine

Trial Locations (1)

37023

Tennessee Oncology, PLLC, Nashville

Sponsors

Collaborators (1)

Aventis Pharmaceuticals

All Listed Sponsors

collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER